Apr 21, 2025, 17:52

NCI: Ruth L. Kirschstein NRSA for Individual Predoctoral MD/PhD Degree Fellows

The NCI Ruth L. Kirschstein F30 Award supports promising MD/PhD candidates conducting cancer-focused research during their training. This mechanism facilitates the development of the next generation of clinician-scientists committed to a research career in cancer biology, prevention, diagnosis, or treatment. Applications must show a clear cancer focus and significant intellectual contributions from the candidate.

Eligibility

Enrolled in an accredited U.S. MD/PhD, DO/PhD, DDS/PhD, or AuD/PhD program
Must be within 48 months of matriculation into the dual-degree program at the time of application
Must be a U.S. citizen, noncitizen national, or permanent resident by the time of award activation
Not eligible: Foreign nationals with student visas
Must commit full-time effort (at least 40 hours/week)
Must not duplicate research funded by the sponsor’s active or pending awards
Support may be requested for up to 6 years

Budget

2024 Stipend: 28,224 USD per year
Tuition & Fees: NCI pays 60% up to 21,000 USD/year
Training-related expenses: Up to 4,750 USD/year for insurance, supplies, travel, etc.
Supports 2 full years of medical school, regardless of PhD duration
No research costs covered—external research funding must be confirmed

Application Deadlines

Cycle 1: April 8, 2025 → Earliest Start: December 2025
Cycle 2: August 8, 2025 → Earliest Start: April 2026
Cycle 3: December 8, 2025 → Earliest Start: July 2026

(If deadline falls on a weekend/holiday, applications are accepted the next business day)

How to Apply

Applications must be submitted electronically via NIH’s SF424 R&R Individual Fellowship Application Guide
Refer to PA-23-260 or PA-23-261 for program specifics
A clear cancer-relevant research training plan and distinction from sponsor’s research is required
For help, contact NCI program staff listed in the NOFO or visit the Cancer Training Branch FAQ

Review and Selection

Peer-reviewed by CSR and NCI
Based on scientific merit, innovation, candidate potential, sponsor training plan, and relevance to NCI’s mission
Final award based on funding availability and review ranking

biomedical fellowships cancer Cancer Education Cancer Prevention cancer research training doctoral research dual-degree support F30 fellowship immunology training MD/PhD training NCI fellowship NCI funding NIH fellowships OncoDaily Oncology Ruth L. Kirschstein NRSA

Oncologist Near Me – Razelle Kurzrock: Revolutionizing Cancer Treatment Through Precision Medicine

Smoking and Bladder Cancer: What You Need to Know to Protect Yourself

Cervical Cancer Screening: Who Needs a Pap Smear or HPV Test and When?

Clinical Trials in Cancer Care: What They Are, How to Join, and What to Expect

Linda Evangelista and Breast Cancer: How She Went Against, How She Survived, and More